Journal article
Distinct Roles of Wnt/ β -Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
Mediators of inflammation, Vol.2017, pp.3520581-16
2017
DOI: 10.1155/2017/3520581
PMCID: PMC5447271
PMID: 28588349
Abstract
Wnt signaling pathways are tightly controlled under a physiological condition, under which they play key roles in many biological functions, including cell fate specification and tissue regeneration. Increasing lines of evidence recently demonstrated that a dysregulated activation of Wnt signaling, particularly the Wnt/
-catenin signaling, was involved in the pathogenesis of chronic pulmonary diseases, such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). In this respect, Wnt signaling interacts with other cellular signaling pathways to regulate the initiation and pathogenic procedures of airway inflammation and remodeling, pulmonary myofibroblast proliferation, epithelial-to-mesenchymal transition (EMT), and development of emphysema. Intriguingly, Wnt/
-catenin signaling is activated in IPF; an inhibition of this signaling leads to an alleviation of pulmonary inflammation and fibrosis in experimental models. Conversely, Wnt/
-catenin signaling is inactivated in COPD tissues, and its reactivation results in an amelioration of airspace enlargement with a restored alveolar epithelial structure and function in emphysema models. These studies thus imply distinct mechanisms of Wnt/
-catenin signaling in the pathogenesis of these two chronic pulmonary diseases, indicating potential targets for COPD and IPF treatments. This review article aims to summarize the involvement and pathogenic roles of Wnt signaling pathways in the COPD and IPF, with a focus on the implication of Wnt/
-catenin signaling as underlying mechanisms and therapeutic targets in these two incurable diseases.
Details
- Title: Subtitle
- Distinct Roles of Wnt/ β -Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
- Creators
- Juan Shi - Center of Laboratory Medicine, General Hospital of Ningxia Medical University, Yinchuan 750004, ChinaFeng Li - Institute of Human Stem Cell Research, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, ChinaMeihui Luo - Center of Laboratory Medicine, General Hospital of Ningxia Medical University, Yinchuan 750004, ChinaJun Wei - Institute of Human Stem Cell Research, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, ChinaXiaoming Liu - Institute of Human Stem Cell Research, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China
- Resource Type
- Journal article
- Publication Details
- Mediators of inflammation, Vol.2017, pp.3520581-16
- DOI
- 10.1155/2017/3520581
- PMID
- 28588349
- PMCID
- PMC5447271
- NLM abbreviation
- Mediators Inflamm
- ISSN
- 0962-9351
- eISSN
- 1466-1861
- Publisher
- United States
- Grant note
- DOI: 10.13039/501100001809, name: National Natural Science Foundation of China, award: 81460247, 31472191
- Language
- English
- Date published
- 2017
- Academic Unit
- Anatomy and Cell Biology
- Record Identifier
- 9984025465302771
Metrics
30 Record Views